An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cells.


Creative Commons License

Rizk S., Luchniak A., Uysal S., Brawley C., Rock R., Kossiakoff A.

Proceedings of the National Academy of Sciences of the United States of America, vol.106, pp.11011-5, 2009 (SCI-Expanded) identifier identifier identifier